Investors Rewire Stock Trades to Find Trillions in Hidden Assets

(Bloomberg) -- Ask Moderna Inc. bulls how the money-losing biotech firm has just become a $28 billion stock, and they’ll play up its status as a frontrunner to deliver a drug that ends the pandemic.